Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries.
Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries.
复制标题
抗Interleukin-6的局部纳米传递的新颖应用可保护器官移植免受缺血 - 再灌注损伤。
DOI:
10.1111/ajt.14266
复制
发表时间:
2017-09
期刊:
影响因子:
--
通讯作者:
Abdi R
中科院分区:
文献类型:
--
作者:
Solhjou Z;Uehara M;Bahmani B;Maarouf OH;Ichimura T;Brooks CR;Xu W;Yilmaz M;Elkhal A;Tullius SG;Guleria I;McGrath MM;Abdi R
Ischemia reperfusion injury (IRI) evokes intra-graft inflammatory responses, which markedly augment alloimmune responses against the graft. Understanding the mechanisms underlying these responses is fundamental to develop therapeutic regimens to prevent/ameliorate organ IRI. Here, we demonstrate that IRI results in a marked increase in mitochondrial damage and autophagy in dendritic cells (DC). While autophagy is a survival mechanism for ischemic DC, it also augments their production of IL6. Allograft derived dendritic cells (ADDC) lacking autophagy related gene 5 (Atg5) showed higher death rates post-transplantation. Transplanted ischemic hearts from CD11cCre/Atg5 conditional knockout mice showed marked reduction in intra-graft expression of IL6 as compared to controls. To antagonize the effect of IL6 locally in the heart, we synthesized novel anti-IL6 nanoparticles with capacity for controlled release of anti-IL6 over time. As compared to systemic delivery of anti-IL6, localized delivery of anti-IL6 significantly reduced chronic rejection with a markedly lower amount administered. Despite improved allograft histology, there were no changes to splenic T cell populations, illustrating the importance of local IL6 in driving chronic rejection after IRI. These data carry potential clinical significance, by identifying an innovative, targeted strategy to manipulate organs prior to transplantation to diminish inflammation, leading to improved long term outcomes.
登录
查看更多内容
DOI:
10.1016/j.clim.2015.04.013
发表时间:
2015-09
期刊:
Clinical immunology (Orlando, Fla.)
影响因子:
--
作者:
Fisher JD;Acharya AP;Little SR
通讯作者:
Little SR
DOI:
10.4049/jimmunol.1100766
发表时间:
2011-12-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Booth AJ;Grabauskiene S;Wood SC;Lu G;Burrell BE;Bishop DK
通讯作者:
Bishop DK
DOI:
10.1084/jem.20110640
发表时间:
2011-12-19
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ireland JM;Unanue ER
通讯作者:
Unanue ER
影响因子:
5.4
作者:
Baratin, M;Bonin, K;Daniel, C
通讯作者:
Daniel, C
影响因子:
7.7
作者:
Fiorina, Paolo;Jurewicz, Mollie;Abdi, Reza
通讯作者:
Abdi, Reza